Systemic sclerosis and the heart: current diagnosis and management

Area of Science:

• Cardiology
• Rheumatology
• Systemic Sclerosis Research

Background:

• Cardiac involvement in systemic sclerosis (SSc) is a critical determinant of patient survival.
• Understanding the epidemiology, screening, diagnosis, and treatment of cardiac manifestations in SSc is essential.

Purpose of the Study:

• To review recent advancements in understanding cardiac involvement in SSc.
• To highlight key epidemiological findings, diagnostic innovations, and therapeutic strategies.

Main Methods:

• Review of recent epidemiological studies on cardiac involvement in SSc.
• Evaluation of diagnostic tools including echocardiography and natriuretic peptides.
• Analysis of current treatment approaches, particularly calcium channel blockers.

Main Results:

• Prevalence and risk factors for left ventricular (LV) systolic dysfunction in SSc are better defined, with diffuse cutaneous SSc patients being most vulnerable.
• Tissue Doppler echocardiography and natriuretic peptides offer insights into subclinical cardiac dysfunction.
• Emerging techniques like speckle-tracking echocardiography and advanced imaging show promise for further understanding.
• Observational data supports calcium channel blockers for microvascular ischemia and LV dysfunction prevention, though RCTs are pending.

Conclusions:

• Recent research has enhanced the understanding of cardiac SSc.
• Significant questions persist regarding optimal screening, diagnosis, and treatment protocols.
• Future multicenter studies and novel diagnostic methods are expected to improve patient outcomes.